Skip to main content

Table 1 Sustained virologic response (SVR) by age, gender and fibrosis stage (N = 1525), nationwide HCV elimination program, Georgia, April 28, 2015–September 30, 2016

From: High sustained viral response among HCV genotype 3 patients with advanced liver fibrosis: real-world data of HCV elimination program in Georgia

  Total n (%)
N = 1525
SVR achieved n (%)
N = 1374
Unadjusted OR and 95% CI Adjusted OR and 95% CI
Age group
 18–30 7 7 (100.00)  
 31–45 411 393 (95.62) 1  
 46–60 986 862 (87.42) 0.32 (0.19, 0.53)  
 > 60 121 112 (92.56) 0.57 (0.25, 1.30)  
Gender
 Male 1450 1300 (89.66) 1  
 Female 75 74 (98.67) 8.54 (1.18, 61.87)  
Fibrosis stage
 F4 892 764 (85.65) 1 1
 F3 or F3/F4 633 610 (96.37) 4.44 (2.82, 7.01) 4.18 (2.64, 6.61)
Treatment regimen
 SOF/RBV 566 449 (79.33) 1 1
 SOF/INF/RBV 959 925 (96.45) 7.09 (4.76, 10.56) 6.72 (4.49, 10.06)